❌

Reading view

ViSR-KGC: Visual Subgraph Reasoning with Vision-Language Models for Multimodal Knowledge Graph Completion

arXiv:2608.05833v3 Announce Type: replace Abstract: Knowledge graph completion (KGC) aims to infer missing entities or relations from incomplete graph structures, and has evolved into multimodal knowledge graph completion (MMKGC), where entities are associated with multiple modalities such as text and images. Traditional representation learning approaches follow the embedding-based paradigm and may struggle when relation-specific evidence is limited. Meanwhile, LLM-based reasoning methods typically linearize graph structures into textual prompts, which obscures structural topology and neglects vital visual information. While vision-language models (VLMs) excel at multimodal reasoning, they cannot natively interpret structured graph topology, particularly when it comes to knowledge graphs where nodes and edges carry complex semantics. To bridge this gap, we propose ViSR-KGC, a visual subgraph reasoning approach for KGC. It integrates three complementary capabilities to capture semantic correlations: identifying global topology dependencies via representation learning, analyzing local multimodal evidence using VLMs, and providing necessary commonsense knowledge inherent in pre-trained models. Based on learned multimodal embeddings, our framework first extracts a compact and query-aware subgraph from the MMKG. Then, this subgraph is transformed into a visually interpretable image using a layout strategy selected through empirical comparison. Finally, the visualized subgraph, entity images, textual descriptions, and candidate answers are combined into a unified prompt, enabling the VLM to infer the missing entity.
  •  

Artificial intelligence-assisted early screening of lung cancer and accurate diagnosis of pulmonary nodules: research progress and clinical prospects from radiomics to multi-omics integration: a narrative review

J Thorac Dis. 2026 May 31;18(5):537. doi: 10.21037/jtd-2026-1-0315. Epub 2026 Apr 30.

ABSTRACT

BACKGROUND AND OBJECTIVE: Lung cancer remains one of the leading causes of cancer-related death worldwide. Although low-dose computed tomography (LDCT) has improved early detection, false-positive results, overdiagnosis, and interobserver variability continue to limit screening efficiency and downstream management of pulmonary nodules. This narrative review summarizes recent progress in artificial intelligence (AI)-assisted screening, radiomics-based nodule characterization, and multi-omics integration for the precision diagnosis of lung cancer.

METHODS: A narrative review with thematic analysis was conducted using representative literature on AI-assisted lung cancer screening, quantitative imaging analysis of pulmonary nodules, radiogenomic and multi-omics integration, and clinical translation challenges. Studies were synthesized to highlight technical advances, diagnostic performance, strengths, limitations, and barriers to implementation.

KEY CONTENT AND FINDINGS: AI improves nodule detection, second-reader support, workflow efficiency, and malignancy-risk estimation in LDCT screening. Radiomics converts CT images into quantitative features that can improve discrimination between benign and malignant nodules, especially when combined with clinical variables or deep-learning models. Beyond imaging alone, radiogenomic and other multi-omics approaches link imaging phenotypes with molecular alterations, treatment response, and prognosis, thereby supporting more individualized management. However, current evidence remains limited by dataset heterogeneity, retrospective design, limited interpretability, and insufficient multicenter prospective validation.

CONCLUSIONS: AI-based imaging and multi-omics integration offer a promising pathway toward earlier detection and more precise diagnosis of lung cancer. Broader clinical adoption will depend on standardized data acquisition, robust external validation, interpretable models, and careful governance of privacy, ethics, and workflow integration.

PMID:42306713 | PMC:PMC13266817 | DOI:10.21037/jtd-2026-1-0315

  •  
❌